These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33267583)

  • 1. The Chiron Approach to (3
    Ghosh AK; Markad SB; Robinson WL
    J Org Chem; 2021 Jan; 86(1):1216-1222. PubMed ID: 33267583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric One-Pot Synthesis of (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol: A Key Component of Current HIV Protease Inhibitors.
    Sevenich A; Liu GQ; Arduengo AJ; Gupton BF; Opatz T
    J Org Chem; 2017 Jan; 82(2):1218-1223. PubMed ID: 27997193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective and efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol.
    Quaedflieg PJ; Kesteleyn BR; Wigerinck PB; Goyvaerts NM; Vijn RJ; Liebregts CS; Kooistra JH; Cusan C
    Org Lett; 2005 Dec; 7(26):5917-20. PubMed ID: 16354099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient synthesis of (3R,3aS,6aR)- hexahydrofuro[2,3-b]furan-3-ol from glycolaldehyde.
    Canoy WL; Cooley BE; Corona JA; Lovelace TC; Millar A; Weber AM; Xie S; Zhang Y
    Org Lett; 2008 Mar; 10(6):1103-6. PubMed ID: 18290653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Synthesis of the Bicyclic Darunavir Side Chain: (3
    Moore GL; Stringham RW; Teager DS; Yue TY
    Org Process Res Dev; 2017 Jan; 21(1):98-106. PubMed ID: 28539755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective photochemical 1,3-dioxolane addition to 5-alkoxymethyl-2(5H)-furanone: synthesis of bis-tetrahydrofuranyl ligand for HIV protease inhibitor UIC-94017 (TMC-114).
    Ghosh AK; Leshchenko S; Noetzel M
    J Org Chem; 2004 Nov; 69(23):7822-9. PubMed ID: 15527257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Stereoselective Anti-Aldol Route to (3
    Ghosh AK; Li J; Perali RS
    Synthesis (Stuttg); 2006 Sep; 2006(18):3015-3018. PubMed ID: 30443083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of gem-difluoro-bis-tetrahydrofuran as P2 ligand for HIV-1 protease inhibitors to improve brain penetration: synthesis, X-ray studies, and biological evaluation.
    Ghosh AK; Yashchuk S; Mizuno A; Chakraborty N; Agniswamy J; Wang YF; Aoki M; Gomez PM; Amano M; Weber IT; Mitsuya H
    ChemMedChem; 2015 Jan; 10(1):107-15. PubMed ID: 25336073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance.
    Ghosh AK; Sridhar PR; Leshchenko S; Hussain AK; Li J; Kovalevsky AY; Walters DE; Wedekind JE; Grum-Tokars V; Das D; Koh Y; Maeda K; Gatanaga H; Weber IT; Mitsuya H
    J Med Chem; 2006 Aug; 49(17):5252-61. PubMed ID: 16913714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Darunavir: A comprehensive profile.
    Darwish IA; Al-Majed AA; Alsaif NA; Bakheit AH; Herqash RN; Alzaid A
    Profiles Drug Subst Excip Relat Methodol; 2021; 46():1-50. PubMed ID: 33461696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Photochemical Route to Optically Active Hexahydro-4
    Ghosh AK; Robinson WL
    J Org Chem; 2019 Aug; 84(15):9801-9805. PubMed ID: 31310117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Enzymatic Route to the Synthesis of Tricyclic Fused Hexahydrofuranofuran P2-Ligand for a Series of Highly Potent HIV-1 Protease Inhibitors.
    Ghosh AK; Sharma A; Ghazi S
    Tetrahedron Lett; 2024 Apr; 140():. PubMed ID: 38586565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.
    Ghosh AK; Chapsal BD; Weber IT; Mitsuya H
    Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective Synthesis of Cyclopentyltetrahydrofuran (Cp-THF), an Important High-Affinity P2-Ligand for HIV-1 Protease Inhibitors.
    Ghosh AK; Takayama J
    Tetrahedron Lett; 2008 May; 49(21):3409-3412. PubMed ID: 18548130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir.
    Aoki M; Hayashi H; Yedidi RS; Martyr CD; Takamatsu Y; Aoki-Ogata H; Nakamura T; Nakata H; Das D; Yamagata Y; Ghosh AK; Mitsuya H
    J Virol; 2015 Nov; 90(5):2180-94. PubMed ID: 26581995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conserved hydrogen-bonding network of P2 bis-tetrahydrofuran-containing HIV-1 protease inhibitors (PIs) with a protease active-site amino acid backbone aids in their activity against PI-resistant HIV.
    Yedidi RS; Garimella H; Aoki M; Aoki-Ogata H; Desai DV; Chang SB; Davis DA; Fyvie WS; Kaufman JD; Smith DW; Das D; Wingfield PT; Maeda K; Ghosh AK; Mitsuya H
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3679-88. PubMed ID: 24752271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselective Synthesis of the HIV Protease Inhibitor Darunavir and Related Derivatives via a Titanium Tetrachloride-Mediated Asymmetric Glycolate Aldol Addition Reaction.
    Witte JM; Ayim E; Sams CJ; Service JB; Kant CC; Bambalas L; Wright D; Carter A; Moran K; Rohrig IG; Ferrence GM; Hitchcock SR
    J Org Chem; 2024 Jul; 89(13):9569-9585. PubMed ID: 38916048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Darunavir: a review of its use in the management of HIV infection in adults.
    McKeage K; Perry CM; Keam SJ
    Drugs; 2009; 69(4):477-503. PubMed ID: 19323590
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.